News tagged ‘BasicResearch’ clear
- Researchers at Dana-Farber Cancer Institute have found a
previously unknown molecular pathway in mice that spurs the growth of
new blood vessels when body parts are jeopardized by poor circulation.
- When a form of cancer that begins in the milk ducts of the breast
invades neighboring tissue to spread to other parts of the body, the
cause lies not in the tumor cells themselves but in a group of abnormal
surrounding cells that cause the walls of the duct to deteriorate like a
rusty pipe, according to a new study led by Dana-Farber Cancer
Tags: BasicResearch, BreastCancer
- Testifying today at a U.S. Senate Committee hearing on federal priorities for the fight against cancer, Dana-Farber President Edward J. Benz, Jr., MD, urged legislators to view cancer research through the widest possible prism.
Tags: BasicResearch, Grants
- David Pellman, MD, a pediatric oncologist at Dana-Farber and
Children's Hospital Boston, is one of 56 scientists just selected as an
investigator of the Howard Hughes Medical Institute, a non-profit
medical research organization that ranks as one of the nation's largest
Tags: BasicResearch, ChildhoodCancer
- Scientists at Dana-Farber report they have blocked the
development of prostate tumors in cancer-prone mice by knocking out a
molecular unit they described as a "powerhouse" that drives runaway cell
Tags: BasicResearch, ProstateCancer
- Calorie-burning brown fat cells generated from muscle precursor cells could help with future obesity treatments.
- A genetic survey of glioblastoma reveals a variety of broken, missing,
and overactive genes, report scientists from Dana-Farber Cancer
Institute and the Broad Institute of MIT and Harvard.
Tags: BasicResearch, Genomics, BrainTumors
- Dana-Farber researchers have identified previously unknown
mutations in a single gene in 8 percent of neuroblastomas, which account
for around 15 percent of all childhood cancer deaths.
Tags: BasicResearch, Genetics
- Dana-Farber scientists have identified a trigger point on a
naturally occurring "death protein" that may lead to designer drugs that
force cancer cells to commit suicide.
- Dana-Farber researchers suggest guidelines and provide tools to minimize
inconsistencies in collecting and sharing data on interactions between
Showing 11-20 of 124 items